medline.ch Onkologie

	Prognostic value of the preoperative lactate dehydrogenase-to-albumin ratio in patients with gastrointestinal cancer. Oncol Lett Yu Y, Yan L, Lv K, Huang T. PMID: 42383287 [PubMed]
	Performance of magnetic-resonance imaging radiomics in prediction of response after neoadjuvant chemotherapy in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Eur J Radiol Open Mohammadzadeh S, Sabet FM, Kiani I, Rahmani SAMS, Mohammadzadeh S, Fayedeh F, Sotoudeh H. PMID: 42383173 [PubMed]
	Endometrial thickness in patients with postmenopausal bleeding and endometrial cancer: A retrospective cohort study. Gynecol Oncol Rep Liu J, Nolin AC, Unnithan S, Erkanli A, Penvose K, Atkins S, Holtzman S, Chess I, Vattakalam A, Blank SV, Wright JD, Albright BB, Hazelton WD, Myers ER, Havrilesky LJ. PMID: 42383153 [PubMed]
	Unveiling the role of glycoproteins in hepatocellular carcinoma: from biomarkers to therapeutic interventions. 3 Biotech Nadeem A, Baskar B, Gupta S. PMID: 42383071 [PubMed]
	Cardiovascular Safety of Next-Generation Antibody-Drug Conjugates in HER2-Low and Triple-Negative Breast Cancer: A Narrative Review (2020-2025). Cureus Raval R, Acharya S, Hejmadi S, Prakashkar N, Kansara AL, Elmoursy A, Patel Y. PMID: 42382890 [PubMed]
	Incidence of malignant transformation in giant cell tumor of bone following denosumab therapy: a systematic review and meta-analysis. J Bone Oncol Alshaygy IS, Alanezi M, Aldosari O, AlOmar A, Arafah MA, Bobseit A, Alaqeel M, Alaseem A. PMID: 42382831 [PubMed]
	ICG-based NIR fluorescence imaging can help to detect residual giant cell tumor of bone after intralesional curettage: Results of two-year follow-up. J Bone Oncol Wang H, Yang Y, Qu H, Huang S, Wang R, Liu X, Guo W. PMID: 42382830 [PubMed]
	Exosomal microRNAs in colorectal cancer communication networks: implications for metastasis, therapy resistance, and precision medicine. Front Immunol Maurya AK, Mirza S. PMID: 42382781 [PubMed - indexed for MEDLINE]
	Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective. Front Immunol Wu D, Yu Q, Wu Q, Wang X, Wei H, Li F, Li G, Wang X, Wang X. PMID: 42382778 [PubMed - indexed for MEDLINE]
	Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer. Front Immunol Zhu H, Yi W, Wu Y, Li R, Zhou B. PMID: 42382771 [PubMed - in process]
	Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study. Front Immunol Wang C, He S, Li D, Zhang B, Dai Y, Li C, Li X, Kang L, Yang S, Zhang S, Fan N, Chang H, Wu G, Yue Z, Ma J, Shang P. PMID: 42382757 [PubMed - indexed for MEDLINE]
	Efficacy of PD-1/PD-L1 and LAG-3 immune checkpoint inhibitors in the treatment of patients with solid tumor. Front Immunol Hu D, Duan J, Xie P, Li J, Zhao L, Chen B, Lu R, Tang H, Zheng X, Qu L. PMID: 42382737 [PubMed - indexed for MEDLINE]
	The gut microbiome in colorectal cancer: molecular paradigms and translational frontiers. Front Bioeng Biotechnol Liu Y, Mei D. PMID: 42382671 [PubMed]
	Erythropoietin in tissue engineering and beyond: a multifunctional macromolecule with emerging roles in organoids, immune modulation, and cancer research. Front Bioeng Biotechnol Sanghvi G, Bellucci S, Ballal S, Ariffin IA, Singh A, Sabarivani A, Ray S, Jain B, Nainwal P, Deepak A. PMID: 42382668 [PubMed]
	Case Report: Pediatric nasopharyngeal carcinoma masquerading as benign lymphadenopathy: diagnostic pitfalls in two cases. Front Pediatr Qiu Y, Cheng Y, Lin A, Li H, Liu J, Zhang W. PMID: 42382649 [PubMed]
	Irreversible electroporation in focal therapy for prostate cancer: current status and future directions. Prostate Int Durazo-Ruiz FO, Roldán-Testillano R, Rodriguez-Sanchez L, Laguna MP, Mendez-Bisgaard LN, Arezki A, Elkhatib H, Hevia-Feliu A, Zhang K, Fainberg J, Perlis N, Rosette J, Miñana-López B, de Reijke TM, Anidjar M, Emberton M, Stricker PD, Sanchez-Salas R. PMID: 42382550 [PubMed]
	Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects. Prostate Int Fattahi MR, Shoja F, Mojaradi MA, Nazarinezhad P, Dehghanbanadaki H, Arefnezhad R, Rezaei-Tazangi F, Azimi H. PMID: 42382546 [PubMed]
	Research Progress of HER2 in Cervical Carcinoma. Cancer Manag Res Yang X, Tang Y, Liu G, Hui H, Guo L, Li N, Zhou Y. PMID: 42382464 [PubMed]
	Colorectal Cancer Progression and Bone Metastasis: Molecular Mechanisms, Tumor Microenvironment, and Tumor-Bone Crosstalk. Cancer Manag Res Qi X, Hao S, Sun Y, Li M, Yang J, Kang L, Zhang L, Wang H. PMID: 42382463 [PubMed]
	Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response. Adv Radiat Oncol Chelvarajah RC, Bartolucci DD, Javor J, Taylor E, Liu ZA, Ye XY, Serban M, Cummings B, Dawson L, Keilty D, Hahn E, Tsai CJ, Wong P. PMID: 42382438 [PubMed]

Artikel 1 - 20 / 1951084

Seite 1 von 97555

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung